Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Global Health Security and Diplomacy Act of 2020
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
S. 3829 The Global Health Security and Diplomacy Act. Issues related to international price controls on drugs and devices. Proposals regarding infant and child nutrition marketing. Proposals related to the China Phase One Trade Agreement.
Global Health Security and Diplomacy Act of 2020
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
S. 3829 The Global Health Security and Diplomacy Act. Issues related to international price controls on drugs and devices. Proposals regarding infant and child nutrition marketing. Proposals related to the China Phase One Trade Agreement.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2020 · third_quarter · 3A
S. 3829 The Global Health Security and Diplomacy Act. Issues related to international price controls on drugs and devices. Proposals regarding infant and child nutrition marketing. Proposals related to the China Phase One Trade Agreement.
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)
Source: Senate LDA
Foreign Investment Risk Review Modernization Act of 2018
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
S. 2098 Foreign Investment Risk Review Modernization Act. Proposals regarding modernization of the North America Free Trade Agreement (NAFTA). Proposals regarding infant nutrition marketing. Issues related to U.S. global health programs. Issues related to international price controls on drugs and devices.
Foreign Investment Risk Review Modernization Act of 2018
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
S. 2098 Foreign Investment Risk Review Modernization Act. Proposals regarding modernization of the North America Free Trade Agreement (NAFTA). Proposals regarding infant nutrition marketing. Issues related to U.S. global health programs. Issues related to international price controls on drugs and devices.
Middle Class Health Benefits Tax Repeal Act of 2015
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
S. 2045 Middle Class Health Benefits Tax Repeal Act of 2015. H.R. 2050 Middle Class Health Benefits Tax Repeal Act of 2015. Proposals to reform domestic and international tax structures.
H.R. 4432 Safe and Accurate Food Labeling Act of 2015. Initiatives regarding Trade Implications of International Food Labeling Requirements. Proposals to reduce adult malnutrition and hospital re-admissions.
Ensuring Patient Access to Critical Breakthrough Products Act of 2016
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
S. 1622 FDA Device Accountability Act of 2015. H.R. 5009 Ensuring Patient Access to Critical Breakthrough Products Act of 2016. H.R. 771 Protecting Access to Diabetes Supplies Act of 2015. Proposals regarding payments across healthcare sites of service. Proposals to provide Diagnostic Regulatory Reform.
S. 1622 FDA Device Accountability Act of 2015. H.R. 6 - The 21st Century CURES Act, Sec. 2228. H.R. 771 Protecting Access to Diabetes Supplies Act of 2015. Proposals regarding HHS proposed rule to require informed consent for de-identified clinical specimens. Proposals regarding payments across healthcare sites of service. Proposals to provide Diagnostic Regulatory Reform.
Protecting Access to Diabetes Supplies Act of 2015
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
S. 1622 FDA Device Accountability Act of 2015. H.R. 5009 Ensuring Patient Access to Critical Breakthrough Products Act of 2016. H.R. 771 Protecting Access to Diabetes Supplies Act of 2015. Proposals regarding payments across healthcare sites of service. Proposals to provide Diagnostic Regulatory Reform.
Protecting Access to Diabetes Supplies Act of 2015
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
S. 1622 FDA Device Accountability Act of 2015. H.R. 6 - The 21st Century CURES Act, Sec. 2228. H.R. 771 Protecting Access to Diabetes Supplies Act of 2015. Proposals regarding HHS proposed rule to require informed consent for de-identified clinical specimens. Proposals regarding payments across healthcare sites of service. Proposals to provide Diagnostic Regulatory Reform.
S. 1622 FDA Device Accountability Act of 2015. H.R. 5009 Ensuring Patient Access to Critical Breakthrough Products Act of 2016. H.R. 771 Protecting Access to Diabetes Supplies Act of 2015. Proposals regarding payments across healthcare sites of service. Proposals to provide Diagnostic Regulatory Reform.
S. 1622 FDA Device Accountability Act of 2015. H.R. 6 - The 21st Century CURES Act, Sec. 2228. H.R. 771 Protecting Access to Diabetes Supplies Act of 2015. Proposals regarding HHS proposed rule to require informed consent for de-identified clinical specimens. Proposals regarding payments across healthcare sites of service. Proposals to provide Diagnostic Regulatory Reform.
Middle Class Health Benefits Tax Repeal Act of 2015
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
S. 2045 Middle Class Health Benefits Tax Repeal Act of 2015. H.R. 2050 Middle Class Health Benefits Tax Repeal Act of 2015. Proposals to reform domestic and international tax structures.
S. 662 Trade Facilitation and Trade Enforcement Reauthorization Act of 2013. H.R. 2393 Country of Origin Labeling Amendments Act of 2015. H.R. 1314 Trade Act of 2015. Initiatives regarding US-China food safety cooperation. Initiatives regarding Trade Trans-Pacific Partnership (TPP).
H.R. 644/S. 1269 Trade Facilitation and Trade Enforcement Reauthorization Act of 2015. H.R. 2393 Country of Origin Labeling Amendments Act of 2015. H.R. 1314 Trade Act of 2015. (Provisions related to Trade Promotion Authority) Proposals related to international price controls on drugs and devices.
Country of Origin Labeling Amendments Act of 2015
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
S. 662 Trade Facilitation and Trade Enforcement Reauthorization Act of 2013. H.R. 2393 Country of Origin Labeling Amendments Act of 2015. H.R. 1314 Trade Act of 2015. Initiatives regarding US-China food safety cooperation. Initiatives regarding Trade Trans-Pacific Partnership (TPP).
Country of Origin Labeling Amendments Act of 2015
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
H.R. 644/S. 1269 Trade Facilitation and Trade Enforcement Reauthorization Act of 2015. H.R. 2393 Country of Origin Labeling Amendments Act of 2015. H.R. 1314 Trade Act of 2015. (Provisions related to Trade Promotion Authority) Proposals related to international price controls on drugs and devices.
Country of Origin Labeling Amendments Act of 2015
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
H.R. 2393 Country of Origin Labeling Amendments Act of 2015. Issues related to international price controls on drugs and devices.
Country of Origin Labeling Amendments Act of 2015
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
H.R. 2393 Country of Origin Labeling Amendments Act of 2015. Issues related to international price controls on drugs and devices.
H.R. 4432 Safe and Accurate Food Labeling Act of 2015. Proposals to reduce adult malnutrition and hospital re-admissions. Initiatives regarding Trade Implications of International Food Labeling Requirements.
Trade Facilitation and Trade Enforcement Act of 2015
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
H.R. 644/S. 1269 Trade Facilitation and Trade Enforcement Reauthorization Act of 2015. H.R. 2393 Country of Origin Labeling Amendments Act of 2015. H.R. 1314 Trade Act of 2015. (Provisions related to Trade Promotion Authority) Proposals related to international price controls on drugs and devices.
Trade Facilitation and Trade Enforcement Act of 2015
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
H.R. 644/S. 1269 Trade Facilitation and Trade Enforcement Reauthorization Act of 2015. H.R. 2393 Country of Origin Labeling Amendments Act of 2015. H.R. 1314 Trade Act of 2015. (Provisions related to Trade Promotion Authority) Proposals related to international price controls on drugs and devices.
Safe and Accurate Food Labeling Act of 2014
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
H.R. 4432 Safe and Accurate Food Labeling Act. Proposals to reduce adult malnutrition and hospital re-admissions.
Safe and Accurate Food Labeling Act of 2014
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
H.R. 4432 Safe and Accurate Food Labeling Act. Proposals to reduce adult malnutrition and hospital re-admissions.
Trade Facilitation and Trade Enforcement Reauthorization Act of 2013
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
S. 662 Trade Facilitation and Trade Enforcement Reauthorization Act of 2013. H.R. 2393 Country of Origin Labeling Amendments Act of 2015. H.R. 1314 Trade Act of 2015. Initiatives regarding US-China food safety cooperation. Initiatives regarding Trade Trans-Pacific Partnership (TPP).
Trade Facilitation and Trade Enforcement Reauthorization Act of 2013
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
S. 662 Trade Facilitation and Trade Enforcement Reauthorization Act of 2013. Proposals regarding Country of Origin Labeling and marketing restrictions. Initiatives regarding Trade Trans-Pacific Partnership (TPP). Initiatives regarding issues related to international price controls on drugs and devices.
Trade Facilitation and Trade Enforcement Reauthorization Act of 2013
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
S. 662 Trade Facilitation and Trade Enforcement Reauthorization Act of 2013 Initiatives regarding Trade Trans-Pacific Partnership (TPP) Proposals regarding Country of Origin Labeling and marketing restrictions
Preserving Access to Life-Saving Medications Act of 2011
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, The Reconciliation Act of 2010 Implementation of Public Law 110-293, Henry J. Hyde U.S. Global Leadership Against HIV/AIDS, TB & Malaria Act H.R. 2245 / S. 296, Preserving Access to Life-Saving Medications Act of 2011 H.R. 5, Protecting Access to Healthcare Act of 2012 H.R. 3497, The MODDERN Cures Act of 2011 H.R. 3207, Modernizing Laboratory Test Standards for Patients Act of 2011 Reauthorization of The Prescription Drug User Fee Act Reauthorization of the Medical Device User Fee Act Policies for FDA product approval reform Proposals to improve viral hepatitis screening and testing
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, The Reconciliation Act of 2010 Implementation of Public Law 110-293, Henry J. Hyde U.S. Global Leadership Against HIV/AIDS, TB & Malaria Act H.R. 2245 / S. 296, Preserving Access to Life-Saving Medications Act of 2011 H.R. 5, Protecting Access to Healthcare Act of 2012 H.R. 3497, The MODDERN Cures Act of 2011 H.R. 3207, Modernizing Laboratory Test Standards for Patients Act of 2011 Reauthorization of The Prescription Drug User Fee Act Reauthorization of the Medical Device User Fee Act Policies for FDA product approval reform Proposals to improve viral hepatitis screening and testing
Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, The Reconciliation Act of 2010 Implementation of Public Law 110-293, Henry J. Hyde U.S. Global Leadership Against HIV/AIDS, TB & Malaria Act H.R. 2245 / S. 296, Preserving Access to Life-Saving Medications Act of 2011 H.R. 5, Protecting Access to Healthcare Act of 2012 H.R. 3497, The MODDERN Cures Act of 2011 H.R. 3207, Modernizing Laboratory Test Standards for Patients Act of 2011 Reauthorization of The Prescription Drug User Fee Act Reauthorization of the Medical Device User Fee Act Policies for FDA product approval reform Proposals to improve viral hepatitis screening and testing
Public Law 111-148, The Patient Protection and Affordable Care Act Public Law 111-152, The Reconciliation Act of 2010 Public Law 110-293, Henry J. Hyde U.S. Global Leadership Against HIV/AIDS, TB & Malaria Act H.R. 3497, MODDERN Cures Act of 2011 H.R.6446, To create incentive for innovative diagnostics by improving the process for determining Medicare payment rates for new tests Proposals to increase security of US drug distribution supply chain Proposals to improve viral hepatitis screening and testing Policies for FDA product approval reform
Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, The Reconciliation Act of 2010 Implementation of Public Law 110-293, Henry J. Hyde U.S. Global Leadership Against HIV/AIDS, TB & Malaria Act S.3187, the Food and Drug Administration Safety and Innovation Act of 2012 H.R. 3497, The MODDERN Cures Act of 2011 Funding for State AIDS Drug Assistance programs under Ryan White Care Act
Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, The Reconciliation Act of 2010 Public Law 110-293, Henry J. Hyde U.S. Global Leadership Against HIV/AIDS, TB & Malaria Act Implemenation of S.3187, The Food and Drug Administration Safety and Innovation Act of 2012 S.27 Preserve Access to Affordable Generics Act H.R. 3497, The MODDERN Cures Act of 2011 H.R.6446, a bill to create incentive for innovative diagnostics by improving the process for determining Medicare payment rates for new tests Proposals to establish a system to improve pharmaceutical traceability
Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, The Reconciliation Act of 2010 Public Law 110-293, Henry J. Hyde U.S. Global Leadership Against HIV/AIDS, TB & Malaria Act Implemenation of S.3187, The Food and Drug Administration Safety and Innovation Act of 2012 S.27 Preserve Access to Affordable Generics Act H.R. 3497, The MODDERN Cures Act of 2011 H.R.6446, a bill to create incentive for innovative diagnostics by improving the process for determining Medicare payment rates for new tests Proposals to establish a system to improve pharmaceutical traceability
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
H.R.5973, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013
Improving Diagnostic Innovations Act of 2012
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, The Reconciliation Act of 2010 Public Law 110-293, Henry J. Hyde U.S. Global Leadership Against HIV/AIDS, TB & Malaria Act Implemenation of S.3187, The Food and Drug Administration Safety and Innovation Act of 2012 S.27 Preserve Access to Affordable Generics Act H.R. 3497, The MODDERN Cures Act of 2011 H.R.6446, a bill to create incentive for innovative diagnostics by improving the process for determining Medicare payment rates for new tests Proposals to establish a system to improve pharmaceutical traceability
Improving Diagnostic Innovations Act of 2012
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
Public Law 111-148, The Patient Protection and Affordable Care Act Public Law 111-152, The Reconciliation Act of 2010 Public Law 110-293, Henry J. Hyde U.S. Global Leadership Against HIV/AIDS, TB & Malaria Act H.R. 3497, MODDERN Cures Act of 2011 H.R.6446, To create incentive for innovative diagnostics by improving the process for determining Medicare payment rates for new tests Proposals to increase security of US drug distribution supply chain Proposals to improve viral hepatitis screening and testing Policies for FDA product approval reform
Improving Diagnostic Innovations Act of 2012
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, The Reconciliation Act of 2010 Public Law 110-293, Henry J. Hyde U.S. Global Leadership Against HIV/AIDS, TB & Malaria Act Implemenation of S.3187, The Food and Drug Administration Safety and Innovation Act of 2012 S.27 Preserve Access to Affordable Generics Act H.R. 3497, The MODDERN Cures Act of 2011 H.R.6446, a bill to create incentive for innovative diagnostics by improving the process for determining Medicare payment rates for new tests Proposals to establish a system to improve pharmaceutical traceability
Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, The Reconciliation Act of 2010 Implementation of Public Law 110-293, Henry J. Hyde U.S. Global Leadership Against HIV/AIDS, TB & Malaria Act S.319, The Pharmaceutical Market Access and Drug Safety Act of 2011 Reauthorization of The Prescription Drug User Fee Act Reauthorization of The Medical Device User Fee Act H.R.5440, Genomics and Personalized Medicine Act of 2010 H.R. 1483, Drug Safety Enhancement Act of 2011 Proposals to reduce health disparities Policies for FDA product approval reform FDA proposals to enhance imported product safety Briefings on medical device techonology
S.17, Medical Device Access and Innovation Protection Act H.R.675, Strengthening Medicare Anti-Fraud Measures Act of 2011 H.R.2190, Medicare Drug Savings Act of 2011 S.1206, Medicare Drug Savings Act of 2011
Preserving Access to Life-Saving Medications Act of 2011
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, The Reconciliation Act of 2010 H.R. 2245 / S. 296, Preserving Access to Life-Saving Medications Act of 2011 S. 27, Preserve Access to Affordable Generics Act H.R. 3026, Safeguarding Americas Pharmaceuticals Act of 2011 H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Amendment #769 Reauthorization of The Prescription Drug User Fee Act Reauthorization of the Medical Device User Fee Act Policies for FDA product approval reform FDA proposals to enhance imported product safety
Preserving Access to Life-Saving Medications Act of 2011
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, The Reconciliation Act of 2010 Implementation of Public Law 110-293, Henry J. Hyde U.S. Global Leadership Against HIV/AIDS, TB & Malaria Act S.319, the Pharmaceutical Market Access and Drug Safety Act of 2011 H.R.2245, Preserving Access to Life-Saving Medications Act of 2011 S.296, Preserving Access to Life-Saving Medications Act of 2011 Reauthorization of The Prescription Drug User Fee Act Reauthorization of The Medical Device User Fee Act Proposals to expand debt ceiling, various proposals related to health care Proposals to advance personalized medicine Proposals to improve viral hepatitis screening and testing Policies for FDA product approval reform Briefings on medical device technology
S.23, Patent Reform Act of 2011 H.R.243, Patent Lawsuit Reform Act of 2011 H.R. 1249, Leahy-Smith America Invents Act
S.23, Patent Reform Act of 2011/ H.R. 243, Patent Lawsuit Reform Act of 2011
Safeguarding America's Pharmaceuticals Act of 2011
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, The Reconciliation Act of 2010 H.R. 2245 / S. 296, Preserving Access to Life-Saving Medications Act of 2011 S. 27, Preserve Access to Affordable Generics Act H.R. 3026, Safeguarding Americas Pharmaceuticals Act of 2011 H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Amendment #769 Reauthorization of The Prescription Drug User Fee Act Reauthorization of the Medical Device User Fee Act Policies for FDA product approval reform FDA proposals to enhance imported product safety
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
Implementation of Public Law 110-275, Medicare DMEPOS Competitive Acquistion Program Proposals to expand competitive bidding for DMEPOS H.R. 675, Strenghten Medicare Anti-Fraud Measures Act of 2011 H.R. 3497, The MODDERN Cures Act of 2011 H.R. 3207, Modernizing Laboratory Test Standards for Patients Act of 2011 Proposals to give the Centers for Medicare and Medicaid authority to use the least costly alternative reimbursement policy Policies to enhance patient access to medicines in Medicare Reimbursement protocols for HIV diagnostics Medciare payment proposals
Implementation of Public Law 110-275, Medicare DMEPOS Competitive Acquistion Program Proposals to expand competitive bidding for DMEPOS H.R. 675, Strenghten Medicare Anti-Fraud Measures Act of 2011 H.R. 3497, The MODDERN Cures Act of 2011 H.R. 3207, Modernizing Laboratory Test Standards for Patients Act of 2011 Proposals to give the Centers for Medicare and Medicaid authority to use the least costly alternative reimbursement policy Policies to enhance patient access to medicines in Medicare Reimbursement protocols for HIV diagnostics Medciare payment proposals
Strengthening Medicare Anti-Fraud Measures Act of 2011
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
Implementation of Public Law 110-275 Medicare DMEPOS Competitive Acquistion Program Proposals to expand competitive bidding for DMEPOS S.17, Medical Device Access and Innovation Protection Act H.R. 675, Strengthening Medicare Anti-Fraud Measures Act of 2011 Proposals to give Center for Medicare and Medicaid Services authority to use the least costly alternative reimbursement policy Policies to enhance patient access to medicines in Medicare Reimbursement protocols for HIV diagnostics Medicare payment proposals
Strengthening Medicare Anti-Fraud Measures Act of 2011
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
S.17, Medical Device Access and Innovation Protection Act H.R.675, Strengthening Medicare Anti-Fraud Measures Act of 2011 H.R.2190, Medicare Drug Savings Act of 2011 S.1206, Medicare Drug Savings Act of 2011
Strengthening Medicare Anti-Fraud Measures Act of 2011
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
Implementation of Public Law 110-275, Medicare DMEPOS Competitive Acquistion Program Proposals to expand competitive bidding for DMEPOS H.R. 675, Strenghten Medicare Anti-Fraud Measures Act of 2011 H.R. 3497, The MODDERN Cures Act of 2011 H.R. 3207, Modernizing Laboratory Test Standards for Patients Act of 2011 Proposals to give the Centers for Medicare and Medicaid authority to use the least costly alternative reimbursement policy Policies to enhance patient access to medicines in Medicare Reimbursement protocols for HIV diagnostics Medciare payment proposals
S.1002, SAFE DOSES Act
Genomics and Personalized Medicine Act of 2010
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, The Reconciliation Act of 2010 Implementation of Public Law 110-293, Henry J. Hyde U.S. Global Leadership Against HIV/AIDS, TB & Malaria Act S.319, The Pharmaceutical Market Access and Drug Safety Act of 2011 Reauthorization of The Prescription Drug User Fee Act Reauthorization of The Medical Device User Fee Act H.R.5440, Genomics and Personalized Medicine Act of 2010 H.R. 1483, Drug Safety Enhancement Act of 2011 Proposals to reduce health disparities Policies for FDA product approval reform FDA proposals to enhance imported product safety Briefings on medical device techonology
S. 515/H.R. 1260 Patent Reform Act of 2009 S.369 Preserve Access to Affordable Generics Act
S. 515/H.R. 1260 Patent Reform Act of 2009 S.369 Preserve Access to Affordable Generics Act
S. 515/H.R. 1260 Patent Reform Act of 2009 S.369 Preserve Access to Affordable Generics Act
S. 515/H.R. 1260 Patent Reform Act of 2009 S. 369 Preserve Access to Affordable Generics Act S. 3804 Combating Online Infringement and Counterfeits Act
S. 515/H.R. 1260 Patent Reform Act of 2009 S.369 Preserve Access to Affordable Generics Act
District of Columbia Hatch Act Reform Act of 2010
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
Health Care Reform Implementation H.R. 3590 Patient Protection and Affordable Care Act H.R. 4872 Health Care and Education Reconciliation Act of 2010 Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, the Reconciliation Act of 2010 H.R. 1548 Pathway for Biosimilars Act S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009 S. 422 Heart Disease Education, Analysis Research, and Treatment for Women Act H.R. 4213 American Jobs and Closing Tax Loopholes Act of 2010 Proposals to address reimbursement of diagnostics Reauthorization of The Prescription Drug User Fee Act (PDUFA) Reauthorization of The Medical Device User Fee Act (MDUFA) Biodefense and pandemic preparedness H.R. 1345/S.540 Medical Device Safety Act of 2009 Policies for FDA product approval process Briefings on eye care
District of Columbia Hatch Act Reform Act of 2010
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
Health Care Reform Implementation H.R. 3590 Patient Protection and Affordable Care Act H.R. 4872 Health Care and Education Reconciliation Act of 2010 Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, the Reconciliation Act of 2010 H.R. 1548 Pathway for Biosimilars Act S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009 S. 422 Heart Disease Education, Analysis Research, and Treatment for Women Act H.R. 4213 American Jobs and Closing Tax Loopholes Act of 2010 Proposals to address reimbursement of diagnostics Reauthorization of The Prescription Drug User Fee Act (PDUFA) Reauthorization of The Medical Device User Fee Act (MDUFA) Biodefense and pandemic preparedness H.R. 1345/S.540 Medical Device Safety Act of 2009 Policies for FDA product approval process Briefings on eye care
Health Care Reform H.R. 3590 Patient Protection and Affordable Care Act H.R. 4872 Health Care and Education Reconciliation Act of 2010 H.R. 1548 Pathway for Biosimilars Act HR 3200: America's Affordable Health Choices Act S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009
Health Care Reform Implementation H.R. 3590 Patient Protection and Affordable Care Act H.R. 4872 Health Care and Education Reconciliation Act of 2010 Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, the Reconciliation Act of 2010 H.R. 1548 Pathway for Biosimilars Act S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009 S. 422 Heart Disease Education, Analysis Research, and Treatment for Women Act H.R. 4213 American Jobs and Closing Tax Loopholes Act of 2010 Proposals to address reimbursement of diagnostics Reauthorization of The Prescription Drug User Fee Act (PDUFA) Reauthorization of The Medical Device User Fee Act (MDUFA) Biodefense and pandemic preparedness H.R. 1345/S.540 Medical Device Safety Act of 2009 Policies for FDA product approval process Briefings on eye care
Health Care Reform H.R. 3590 Patient Protection and Affordable Care Act H.R. 4872 Health Care and Education Reconciliation Act of 2010 H.R. 1548 Pathway for Biosimilars Act HR 3200: America's Affordable Health Choices Act S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009
Health Care Reform Implementation H.R. 3590 Patient Protection and Affordable Care Act H.R. 4872 Health Care and Education Reconciliation Act of 2010 Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, the Reconciliation Act of 2010 H.R. 1548 Pathway for Biosimilars Act S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009 S. 422 Heart Disease Education, Analysis Research, and Treatment for Women Act H.R. 4213 American Jobs and Closing Tax Loopholes Act of 2010 Proposals to address reimbursement of diagnostics Reauthorization of The Prescription Drug User Fee Act (PDUFA) Reauthorization of The Medical Device User Fee Act (MDUFA) Biodefense and pandemic preparedness H.R. 1345/S.540 Medical Device Safety Act of 2009 Policies for FDA product approval process Briefings on eye care
S. 510 Food Safety Modernization Act H.R. 2749 Food Safety Enhancement Act of 2009
S.510 FDA Food Safety Modernization Act H.R. 2749 Food Safety Enhancement Act of 2009
S.510 FDA Food Safety Modernization Act H.R. 2749 Food Safety Enhancement Act of 2009
S.510 FDA Food Safety Modernization Act H.R. 2749 Food Safety Enhancement Act of 2009 S.2766 Medical Foods Equity Act of 2009
S.510 FDA Food Safety Modernization Act H.R. 2749 Food Safety Enhancement Act of 2009 S.2766 Medical Foods Equity Act of 2009
S. 510 FDA Food Safety Modernization Act H.R.2749 Food Safety Enhancement Act of 2009
America's Affordable Health Choices Act of 2009
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
Health Care Reform H.R. 3590 Patient Protection and Affordable Care Act H.R. 4872 Health Care and Education Reconciliation Act of 2010 H.R. 1548 Pathway for Biosimilars Act HR 3200: America's Affordable Health Choices Act S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009
America's Affordable Health Choices Act of 2009
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
Health Care Reform H.R. 3590 Patient Protection and Affordable Care Act H.R. 4872 Health Care and Education Reconciliation Act of 2010 H.R. 1548 Pathway for Biosimilars Act HR 3200: America's Affordable Health Choices Act S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009
To amend title XVIII of the Social Security Act to repeal the Medicare competitive acquisition program for durable medical equipment and prosthetics, orthotics, and supplies (DMEPOS) in a budget neutral manner.
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
PL-110-275 Implementation of Medicare DMEPOS Competitive Acquisition Program H.R. 3790 To amend title XVIII of the Social Security Act to repeal the Medicare competitive acquisition program for durable medical equipment and prosthetics, orthotics, and supplies (DMEPOS) in a budget neutral manner H.R.1321, S. 2404 Medicare Advanced Laboratory Diagnostics Act of 2007
Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implemenation of Public Law 111-152, The Reconciliation Act of 2010 S. 422 Heart Disease Education, Analysis Research, and Treatment for Women Act H.R. 5501, Henry J. Hyde U.S. Global Leadership Against HIV/AIDS, TB & Malaria Act H.R. 5440 - Genomics and Personalized Medicine Act of 2010 H.R. 3974: Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009 S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009 Policies for FDA product approval reform
Foreign Manufacturers Legal Accountability Act of 2010
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
H.R. 4678: Foreign Manufacturers Legal Accountability Act of 2010
Genomics and Personalized Medicine Act of 2010
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implemenation of Public Law 111-152, The Reconciliation Act of 2010 S. 422 Heart Disease Education, Analysis Research, and Treatment for Women Act H.R. 5501, Henry J. Hyde U.S. Global Leadership Against HIV/AIDS, TB & Malaria Act H.R. 5440 - Genomics and Personalized Medicine Act of 2010 H.R. 3974: Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009 S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009 Policies for FDA product approval reform
Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implemenation of Public Law 111-152, The Reconciliation Act of 2010 S. 422 Heart Disease Education, Analysis Research, and Treatment for Women Act H.R. 5501, Henry J. Hyde U.S. Global Leadership Against HIV/AIDS, TB & Malaria Act H.R. 5440 - Genomics and Personalized Medicine Act of 2010 H.R. 3974: Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009 S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009 Policies for FDA product approval reform
Improving Nutrition for America's Children Act
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
S. 3307 Healthy, Hunger-Free Kids Act of 2010 H.R. 5504 Improving Nutrition for America's Children Act Special Supplemental Nutrition Program for Women, Infants and Children (WIC) Reauthorization Initiatives regarding infant nutrition
Food and Drug Administration Globalization Act of 2009
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
Implementation of Public Law 111-148, the Patient Protection and Affordable Care Act Implementation of Public Law 111-152, the Reconciliation Act of 2010 S. 3397 Secure and Responsible Drug Disposal Act of 2010 H.R.759 Food and Drug Administration Globalization Act of 2009 Reauthorization of the Prescription Drug User Fee Act (PDUFA) Reauthorization of the Medical Device User Fee Act (MDUFA) Proposals to address reimbursement of diagnostics
S.510 FDA Food Safety Modernization Act H.R. 2749 Food Safety Enhancement Act of 2009 S.2766 Medical Foods Equity Act of 2009
S.510 FDA Food Safety Modernization Act H.R. 2749 Food Safety Enhancement Act of 2009 S.2766 Medical Foods Equity Act of 2009
Secure and Responsible Drug Disposal Act of 2010
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
Implementation of Public Law 111-148, the Patient Protection and Affordable Care Act Implementation of Public Law 111-152, the Reconciliation Act of 2010 S. 3397 Secure and Responsible Drug Disposal Act of 2010 H.R.759 Food and Drug Administration Globalization Act of 2009 Reauthorization of the Prescription Drug User Fee Act (PDUFA) Reauthorization of the Medical Device User Fee Act (MDUFA) Proposals to address reimbursement of diagnostics
Preserve Access to Affordable Generics Act
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
S. 515/H.R. 1260 Patent Reform Act of 2009 S. 369 Preserve Access to Affordable Generics Act S. 3804 Combating Online Infringement and Counterfeits Act
Preserve Access to Affordable Generics Act
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
S. 515/H.R. 1260 Patent Reform Act of 2009 S.369 Preserve Access to Affordable Generics Act
Preserve Access to Affordable Generics Act
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
S.369 Preserve Access to Affordable Generics Act S. 3804 Combating Online Infringement and Counterfeits Act
Preserve Access to Affordable Generics Act
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
S. 515/H.R. 1260 Patent Reform Act of 2009 S.369 Preserve Access to Affordable Generics Act
Preserve Access to Affordable Generics Act
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
S. 515/H.R. 1260 Patent Reform Act of 2009 S.369 Preserve Access to Affordable Generics Act
Preserve Access to Affordable Generics Act
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
S. 515/H.R. 1260 Patent Reform Act of 2009 S.369 Preserve Access to Affordable Generics Act
Combating Online Infringement and Counterfeits Act
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
S. 515/H.R. 1260 Patent Reform Act of 2009 S. 369 Preserve Access to Affordable Generics Act S. 3804 Combating Online Infringement and Counterfeits Act
Combating Online Infringement and Counterfeits Act
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
S.369 Preserve Access to Affordable Generics Act S. 3804 Combating Online Infringement and Counterfeits Act
Creating American Jobs and Ending Offshoring Act
Client: ABBOTT LABORATORIES · Firm: ABBOTT LABORATORIES
H.R.4173/S.3217 Dodd-Frank Wall Street Reform and Consumer Protection Act S.3816 Creating American Jobs and Ending Offshoring Act H.R.5297 Small Business Jobs and Credit Act of 2010 Proposals Regarding International Revenue Taxation Proposals to Extend the R&D tax credit
Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implemenation of Public Law 111-152, The Reconciliation Act of 2010 S. 422 Heart Disease Education, Analysis Research, and Treatment for Women Act H.R. 5501, Henry J. Hyde U.S. Global Leadership Against HIV/AIDS, TB & Malaria Act H.R. 5440 - Genomics and Personalized Medicine Act of 2010 H.R. 3974: Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009 S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009 Policies for FDA product approval reform
Health Care Reform Implementation H.R. 3590 Patient Protection and Affordable Care Act H.R. 4872 Health Care and Education Reconciliation Act of 2010 Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, the Reconciliation Act of 2010 H.R. 1548 Pathway for Biosimilars Act S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009 S. 422 Heart Disease Education, Analysis Research, and Treatment for Women Act H.R. 4213 American Jobs and Closing Tax Loopholes Act of 2010 Proposals to address reimbursement of diagnostics Reauthorization of The Prescription Drug User Fee Act (PDUFA) Reauthorization of The Medical Device User Fee Act (MDUFA) Biodefense and pandemic preparedness H.R. 1345/S.540 Medical Device Safety Act of 2009 Policies for FDA product approval process Briefings on eye care
Health Care Reform Implementation H.R. 3590 Patient Protection and Affordable Care Act H.R. 4872 Health Care and Education Reconciliation Act of 2010 Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, the Reconciliation Act of 2010 H.R. 1548 Pathway for Biosimilars Act S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009 S. 422 Heart Disease Education, Analysis Research, and Treatment for Women Act H.R. 4213 American Jobs and Closing Tax Loopholes Act of 2010 Proposals to address reimbursement of diagnostics Reauthorization of The Prescription Drug User Fee Act (PDUFA) Reauthorization of The Medical Device User Fee Act (MDUFA) Biodefense and pandemic preparedness H.R. 1345/S.540 Medical Device Safety Act of 2009 Policies for FDA product approval process Briefings on eye care
S.510 FDA Food Safety Modernization Act H.R. 2749 Food Safety Enhancement Act of 2009
S.510 FDA Food Safety Modernization Act H.R. 2749 Food Safety Enhancement Act of 2009 S.2766 Medical Foods Equity Act of 2009
S.510 FDA Food Safety Modernization Act H.R. 2749 Food Safety Enhancement Act of 2009
S. 510 FDA Food Safety Modernization Act H.R.2749 Food Safety Enhancement Act of 2009
S.510 FDA Food Safety Modernization Act H.R. 2749 Food Safety Enhancement Act of 2009 S.2766 Medical Foods Equity Act of 2009
S. 510 Food Safety Modernization Act H.R. 2749 Food Safety Enhancement Act of 2009
S. 515/H.R. 1260 Patent Reform Act of 2009 S.369 Preserve Access to Affordable Generics Act
2020 · second_quarter · 2A
Issues related to U.S. global health programs and pandemic preparedness. Issues related to international price controls on drugs and devices.
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of Management & Budget (OMB), SENATE, U.S. Trade Representative (USTR), White House Office
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2020 · third_quarter · Q3
S. 3829 The Global Health Security and Diplomacy Act. Issues related to international price controls on drugs and devices. Proposals regarding infant and child nutrition marketing. Proposals related to the China Phase One Trade Agreement.
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2020 · second_quarter · Q2
Issues related to U.S. global health programs and pandemic preparedness. Issues related to international price controls on drugs and devices.
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of Management & Budget (OMB), SENATE, U.S. Trade Representative (USTR), White House Office
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2020 · first_quarter · Q1
Issues related to international price controls on drugs and devices. Issues related to U.S. global health programs. Issues related to tariffs on products imported into the United States. Proposals regarding international trade negotiations. Proposals regarding infant and child nutrition marketing.
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2019 · fourth_quarter · Q4
Issues related to international price controls on drugs and devices. Issues related to U.S. global health programs. Issues related to tariffs on products imported into the United States. Proposals regarding US-China trade negotiations.
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2019 · third_quarter · Q3
Issues related to international price controls on drugs and devices.
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2019 · second_quarter · Q2
Proposals regarding US-China trade negotiations. Issues related to international price controls on drugs and devices. Issues related to WHO Guidance on diagnostics. Issues related to PEPFAR.
Filing targets: Defense, Dept of (DOD), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Securities & Exchange Commission (SEC), State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA), White House Office
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2019 · first_quarter · Q1
Proposals regarding infant nutrition marketing. Proposals regarding US-China trade negotiations. Issues related to international price controls on drugs and devices. Issues related to the issuance of the Taiwan Regulations Governing the Management of the Review, Registration, and Permit Issuance of Food and Related Products.
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2018 · third_quarter · 3A
Issues related to U.S. global health programs. Issues related to international price controls on drugs and devices. Issues related to prompt payment by government hospitals.
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2018 · first_quarter · 1A
S. 2098 Foreign Investment Risk Review Modernization Act. Proposals regarding modernization of the North America Free Trade Agreement (NAFTA). Proposals regarding infant nutrition marketing. Issues related to U.S. global health programs. Issues related to international price controls on drugs and devices.
Filing targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2018 · fourth_quarter · Q4
Issues related to U.S. global health programs. Issues related to international price controls on drugs and devices. Issues related to prompt payment by government hospitals.
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2018 · third_quarter · Q3
Issues related to U.S. global health programs. Issues related to international price controls on drugs and devices. Issues related to prompt payment by government hospitals.
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2018 · second_quarter · Q2
Proposals regarding infant nutrition marketing. Issues related to tariffs on products imported into the United States. Issues related to Saudi Government tender requirements. Issues related to international price controls on drugs and devices.
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2018 · first_quarter · Q1
S. 2098 Foreign Investment Risk Review Modernization Act. Proposals regarding modernization of the North America Free Trade Agreement (NAFTA). Proposals regarding infant nutrition marketing. Issues related to U.S. global health programs. Issues related to international price controls on drugs and devices.
Filing targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2017 · fourth_quarter · Q4
Public Law 115-97: The Tax Cuts and Jobs Act of 2017 Proposals to reform domestic and international tax structures. Proposals to suspend or repeal the Medical Device Tax.
Proposals regarding modernization of the North America Free Trade Agreement (NAFTA). Proposals regarding infant nutrition marketing. Issues related to international price controls on drugs and devices. Issues related to WHO Prequalification of medical products.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR), White House Office
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2017 · second_quarter · 2A
Proposals regarding infant nutrition marketing. Proposals regarding modernization of the North American Free Trade Agreement (NAFTA). Issues related to international price controls on drugs and devices. Issues related to WHO Prequalification of medical products.
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), SENATE, U.S. Trade Representative (USTR)
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2017 · first_quarter · 1A
Proposals regarding infant nutrition marketing. Issues related to international price controls on drugs and devices. Issues related to a US Export Certificate. Issues related to WHO Prequalification of medical products.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2017 · third_quarter · Q3
Proposals regarding infant nutrition marketing. Issues related to international price controls on drugs and devices. Issues related to prompt payment by government hospitals.
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2017 · second_quarter · 2A
Proposals regarding infant nutrition marketing. Proposals regarding modernization of the North American Free Trade Agreement (NAFTA). Issues related to international price controls on drugs and devices. Issues related to WHO Prequalification of medical products.
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), SENATE, U.S. Trade Representative (USTR)
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2017 · second_quarter · Q2
Proposals regarding infant nutrition marketing. Proposals regarding modernization of the North American Free Trade Agreement (NAFTA). Issues related to international price controls on drugs and devices. Issues related to WHO Prequalification of medical products.
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), SENATE, U.S. Trade Representative (USTR)
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2017 · first_quarter · Q1
Proposals regarding infant nutrition marketing. Issues related to international price controls on drugs and devices. Issues related to a US Export Certificate. Issues related to WHO Prequalification of medical products.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2016 · fourth_quarter · 4A
Proposals to reform domestic and international tax structures. Proposals to suspend or repeal the Medical Device Tax.
Proposals regarding infant nutrition marketing. Issues related to a US Export Certificate. Issues related to WHO Prequalification of medicinal products. Issues related to international price controls on drugs and devices. Asia-Pacific Economic Cooperation Business Advisory Council.
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2016 · fourth_quarter · Q4
Proposals regarding infant nutrition marketing. Issues related to a US Export Certificate. Issues related to WHO Prequalification of medicinal products. Issues related to international price controls on drugs and devices. Asia-Pacific Economic Cooperation Business Advisory Council.
Proposals to reform domestic and international tax structures. Proposals to suspend or repeal the Medical Device Tax.
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2016 · third_quarter · Q3
Proposals regarding infant nutrition marketing. Issues related to international regulatory review of drugs and devices. Issues related to international price controls on drugs and devices. Asia-Pacific Economic Cooperation Business Advisory Council.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2016 · second_quarter · Q2
Proposals regarding infant nutrition marketing. Issues related to importation of diagnostics devices. Issues related to suppliers of TSRA-licensed and other humanitarian goods. Issues related to international regulatory review of drugs and devices. Issues related to international price controls on drugs and devices.
S. 1622 FDA Device Accountability Act of 2015. H.R. 5009 Ensuring Patient Access to Critical Breakthrough Products Act of 2016. H.R. 771 Protecting Access to Diabetes Supplies Act of 2015. Proposals regarding payments across healthcare sites of service. Proposals to provide Diagnostic Regulatory Reform.
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2016 · first_quarter · Q1
H.R. 4432 Safe and Accurate Food Labeling Act of 2015. Initiatives regarding Trade Implications of International Food Labeling Requirements. Proposals to reduce adult malnutrition and hospital re-admissions.
S. 2045 Middle Class Health Benefits Tax Repeal Act of 2015. H.R. 2050 Middle Class Health Benefits Tax Repeal Act of 2015. Proposals to reform domestic and international tax structures.
S. 1622 FDA Device Accountability Act of 2015. H.R. 6 - The 21st Century CURES Act, Sec. 2228. H.R. 771 Protecting Access to Diabetes Supplies Act of 2015. Proposals regarding HHS proposed rule to require informed consent for de-identified clinical specimens. Proposals regarding payments across healthcare sites of service. Proposals to provide Diagnostic Regulatory Reform.
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2015 · fourth_quarter · 4A
Proposals regarding the 2015 Child Nutrition and WIC Reauthorization Act. Proposals regarding infant nutrition marketing.
H.R. 2393 Country of Origin Labeling Amendments Act of 2015. Issues related to international price controls on drugs and devices.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2015 · fourth_quarter · Q4
Proposals regarding the 2015 Child Nutrition and WIC Reauthorization Act. Proposals regarding infant nutrition marketing.
H.R. 2393 Country of Origin Labeling Amendments Act of 2015. Issues related to international price controls on drugs and devices.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2015 · third_quarter · Q3
Proposals regarding the 2015 Child Nutrition and WIC Reauthorization Act. Proposals regarding infant nutrition marketing.
H.R. 644/S. 1269 Trade Facilitation and Trade Enforcement Reauthorization Act of 2015. H.R. 2393 Country of Origin Labeling Amendments Act of 2015. H.R. 1314 Trade Act of 2015. (Provisions related to Trade Promotion Authority) Proposals related to international price controls on drugs and devices.
H.R. 4432 Safe and Accurate Food Labeling Act of 2015. Proposals to reduce adult malnutrition and hospital re-admissions. Initiatives regarding Trade Implications of International Food Labeling Requirements.
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2015 · second_quarter · Q2
H.R. 4432 Safe and Accurate Food Labeling Act. Proposals to reduce adult malnutrition and hospital re-admissions.
S. 662 Trade Facilitation and Trade Enforcement Reauthorization Act of 2013. H.R. 2393 Country of Origin Labeling Amendments Act of 2015. H.R. 1314 Trade Act of 2015. Initiatives regarding US-China food safety cooperation. Initiatives regarding Trade Trans-Pacific Partnership (TPP).
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2015 · first_quarter · Q1
H.R. 4432 Safe and Accurate Food Labeling Act. Proposals to reduce adult malnutrition and hospital re-admissions.
S. 662 Trade Facilitation and Trade Enforcement Reauthorization Act of 2013. Proposals regarding Country of Origin Labeling and marketing restrictions. Initiatives regarding Trade Trans-Pacific Partnership (TPP). Initiatives regarding issues related to international price controls on drugs and devices.
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2014 · fourth_quarter · Q4
S. 662 Trade Facilitation and Trade Enforcement Reauthorization Act of 2013 Initiatives regarding Trade Trans-Pacific Partnership (TPP) Proposals regarding Country of Origin Labeling and marketing restrictions
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2014 · third_quarter · Q3
S. 744 Border Security, Economic Opportunity, and Immigration Modernization Act of 2013.
Initiatives regarding Trade Trans-Pacific Partnership (TPP).
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2014 · second_quarter · Q2
Initiatives regarding Trade Trans-Pacific Partnership (TPP). International trade policies regarding pharmaceuticals and medical devices. International trade policies regarding nutrition.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2014 · first_quarter · Q1
Initiatives to reduce patient malnutrition. Initiatives to support patient access to therapeutic nutrition. Proposals to modify labeling requirements.
S. 744 Border Security, Economic Opportunity, and Immigration Modernization Act of 2013 H.R. 15 Border Security, Economic Opportunity, and Immigration Modernization Act
Initiatives regarding Trade Promotion Authority (TPA).
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2013 · fourth_quarter · Q4
S. 744 Border Security, Economic Opportunity, and Immigration Modernization Act of 2013 (Visa Issues).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2013 · third_quarter · Q3
S. 744 Border Security, Economic Opportunity, and Immigration Modernization Act of 2013 (Visa Issues).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2013 · second_quarter · 2A
U.S./India Trade Issues regarding health care
S. 744 Border Security, Economic Opportunity, and Immigration Modernization Act of 2013
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2013 · second_quarter · Q2
U.S./India Trade Issues related to health care.
S. 744 Border Security, Economic Opportunity, and Immigration Modernization Act of 2013
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2012 · fourth_quarter · Q4
Public Law 111-148, The Patient Protection and Affordable Care Act Public Law 111-152, The Reconciliation Act of 2010 Public Law 110-293, Henry J. Hyde U.S. Global Leadership Against HIV/AIDS, TB & Malaria Act H.R. 3497, MODDERN Cures Act of 2011 H.R.6446, To create incentive for innovative diagnostics by improving the process for determining Medicare payment rates for new tests Proposals to increase security of US drug distribution supply chain Proposals to improve viral hepatitis screening and testing Policies for FDA product approval reform
Public Law 112-208, The Russia and Moldova Jackson-Vanik Repeal Act of 2012 Trade issues regarding the Trans-Pacific Partnership Agreement
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2012 · third_quarter · Q3
Trade issues regarding the Trans-Pacific Partnership Agreement S.3285, A bill to authorize the extension of of nondiscriminatory treatment (normal trade relations treatment) to products of the Russian Federation. International Intellectual property protection
Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, The Reconciliation Act of 2010 Public Law 110-293, Henry J. Hyde U.S. Global Leadership Against HIV/AIDS, TB & Malaria Act Implemenation of S.3187, The Food and Drug Administration Safety and Innovation Act of 2012 S.27 Preserve Access to Affordable Generics Act H.R. 3497, The MODDERN Cures Act of 2011 H.R.6446, a bill to create incentive for innovative diagnostics by improving the process for determining Medicare payment rates for new tests Proposals to establish a system to improve pharmaceutical traceability
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC), U.S. Trade Representative (USTR)
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2012 · second_quarter · Q2
Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, The Reconciliation Act of 2010 Public Law 110-293, Henry J. Hyde U.S. Global Leadership Against HIV/AIDS, TB & Malaria Act Implemenation of S.3187, The Food and Drug Administration Safety and Innovation Act of 2012 S.27 Preserve Access to Affordable Generics Act H.R. 3497, The MODDERN Cures Act of 2011 H.R.6446, a bill to create incentive for innovative diagnostics by improving the process for determining Medicare payment rates for new tests Proposals to establish a system to improve pharmaceutical traceability
Trade issues regarding the Trans-Pacific Partnership Agreement S.3285, A bill to authorize the extension of of nondiscriminatory treatment (normal trade relations treatment) to products of the Russian Federation. International Intellectual property protection
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC), U.S. Trade Representative (USTR)
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2012 · second_quarter · Q2
Trade issues regarding the Trans-Pacific Partnership Agreement S.3285, A bill to authorize the extension of nondiscriminatory treatment (normal trade relations treatment) to products of the Russian Federation.
Proposals to reform domestic and international tax structures
Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, The Reconciliation Act of 2010 Implementation of Public Law 110-293, Henry J. Hyde U.S. Global Leadership Against HIV/AIDS, TB & Malaria Act S.3187, the Food and Drug Administration Safety and Innovation Act of 2012 H.R. 3497, The MODDERN Cures Act of 2011 Funding for State AIDS Drug Assistance programs under Ryan White Care Act
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2012 · first_quarter · Q1
Proposals to reform domestic and international tax structures R&D Tax Credit, Controlled Foreign Corporation look-through
Trade issues regarding the Trans-Pacific Partnership Agreement International intellectual property protection
Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, The Reconciliation Act of 2010 Implementation of Public Law 110-293, Henry J. Hyde U.S. Global Leadership Against HIV/AIDS, TB & Malaria Act H.R. 2245 / S. 296, Preserving Access to Life-Saving Medications Act of 2011 H.R. 5, Protecting Access to Healthcare Act of 2012 H.R. 3497, The MODDERN Cures Act of 2011 H.R. 3207, Modernizing Laboratory Test Standards for Patients Act of 2011 Reauthorization of The Prescription Drug User Fee Act Reauthorization of the Medical Device User Fee Act Policies for FDA product approval reform Proposals to improve viral hepatitis screening and testing
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2011 · fourth_quarter · Q4
Trade issues regarding the Trans-Pacific Partnership Agreement
Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, The Reconciliation Act of 2010 H.R. 2245 / S. 296, Preserving Access to Life-Saving Medications Act of 2011 S. 27, Preserve Access to Affordable Generics Act H.R. 3026, Safeguarding Americas Pharmaceuticals Act of 2011 H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Amendment #769 Reauthorization of The Prescription Drug User Fee Act Reauthorization of the Medical Device User Fee Act Policies for FDA product approval reform FDA proposals to enhance imported product safety
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2011 · third_quarter · Q3
Implementation of Public Law 111-203, Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, Section 1502
H.R. 1249 Leahy-Smith America Invents Act
Trade issues regarding the Trans-Pacific Partnership Agreement
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2011 · second_quarter · Q2
Biodefense and pandemic preparedness appropriations H.R.2112, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2012, Title 6 H.R.2017, Department of Homeland Security Appropriations Act, 2012 Funding for State AIDS Drug Assistance programs under Ryan White Care Act
Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, The Reconciliation Act of 2010 Implementation of Public Law 110-293, Henry J. Hyde U.S. Global Leadership Against HIV/AIDS, TB & Malaria Act S.319, the Pharmaceutical Market Access and Drug Safety Act of 2011 H.R.2245, Preserving Access to Life-Saving Medications Act of 2011 S.296, Preserving Access to Life-Saving Medications Act of 2011 Reauthorization of The Prescription Drug User Fee Act Reauthorization of The Medical Device User Fee Act Proposals to expand debt ceiling, various proposals related to health care Proposals to advance personalized medicine Proposals to improve viral hepatitis screening and testing Policies for FDA product approval reform Briefings on medical device technology
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2011 · first_quarter · Q1
Proposals to combat theft of medical products
Section 1502, Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010
Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, The Reconciliation Act of 2010 Implementation of Public Law 110-293, Henry J. Hyde U.S. Global Leadership Against HIV/AIDS, TB & Malaria Act S.319, The Pharmaceutical Market Access and Drug Safety Act of 2011 Reauthorization of The Prescription Drug User Fee Act Reauthorization of The Medical Device User Fee Act H.R.5440, Genomics and Personalized Medicine Act of 2010 H.R. 1483, Drug Safety Enhancement Act of 2011 Proposals to reduce health disparities Policies for FDA product approval reform FDA proposals to enhance imported product safety Briefings on medical device techonology
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2010 · fourth_quarter · Q4
S. 510 Food Safety Modernization Act H.R. 2749 Food Safety Enhancement Act of 2009
Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implemenation of Public Law 111-152, The Reconciliation Act of 2010 S. 422 Heart Disease Education, Analysis Research, and Treatment for Women Act H.R. 5501, Henry J. Hyde U.S. Global Leadership Against HIV/AIDS, TB & Malaria Act H.R. 5440 - Genomics and Personalized Medicine Act of 2010 H.R. 3974: Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009 S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009 Policies for FDA product approval reform
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2010 · second_quarter · 2A
S.510 FDA Food Safety Modernization Act H.R. 2749 Food Safety Enhancement Act of 2009
Health Care Reform Implementation H.R. 3590 Patient Protection and Affordable Care Act H.R. 4872 Health Care and Education Reconciliation Act of 2010 Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, the Reconciliation Act of 2010 H.R. 1548 Pathway for Biosimilars Act S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009 S. 422 Heart Disease Education, Analysis Research, and Treatment for Women Act H.R. 4213 American Jobs and Closing Tax Loopholes Act of 2010 Proposals to address reimbursement of diagnostics Reauthorization of The Prescription Drug User Fee Act (PDUFA) Reauthorization of The Medical Device User Fee Act (MDUFA) Biodefense and pandemic preparedness H.R. 1345/S.540 Medical Device Safety Act of 2009 Policies for FDA product approval process Briefings on eye care
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2010 · first_quarter · 1A
S.510 FDA Food Safety Modernization Act H.R. 2749 Food Safety Enhancement Act of 2009 S.2766 Medical Foods Equity Act of 2009
FY 2011 Budget Biodefense and pandemic preparedness
Health Care Reform H.R. 3590 Patient Protection and Affordable Care Act H.R. 4872 Health Care and Education Reconciliation Act of 2010 H.R. 1548 Pathway for Biosimilars Act HR 3200: America's Affordable Health Choices Act S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2010 · third_quarter · Q3
Implementation of Public Law 111-148, the Patient Protection and Affordable Care Act Implementation of Public Law 111-152, the Reconciliation Act of 2010 S. 3397 Secure and Responsible Drug Disposal Act of 2010 H.R.759 Food and Drug Administration Globalization Act of 2009 Reauthorization of the Prescription Drug User Fee Act (PDUFA) Reauthorization of the Medical Device User Fee Act (MDUFA) Proposals to address reimbursement of diagnostics
Biodefense and Pandemic Preparedness appropriations Funding for state AIDS drug assistance programs under the Ryan White Care Act Appropriations for Food & Drug Administration and Centers for Disease Control Funding for Hepatitis screening, prevention & treatment
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2010 · second_quarter · Q2
S. 515/H.R. 1260 Patent Reform Act of 2009 S.369 Preserve Access to Affordable Generics Act
S.510 FDA Food Safety Modernization Act H.R. 2749 Food Safety Enhancement Act of 2009
International Intellectual Property Protection
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2010 · first_quarter · Q1
Health Care Reform H.R. 3590 Patient Protection and Affordable Care Act H.R. 4872 Health Care and Education Reconciliation Act of 2010 H.R. 1548 Pathway for Biosimilars Act HR 3200: America's Affordable Health Choices Act S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009
Proposals to extend the R&D tax credit Proposals regarding international revenue taxation H.R. 4173Wall Street Reform and Consumer Protection Act of 2009
S. 515/H.R. 1260 Patent Reform Act of 2009 S.369 Preserve Access to Affordable Generics Act
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2009 · third_quarter · 3A
S.510 FDA Food Safety Modernization Act H.R.2749 Food Safety Enhancement Act of 2009
S. 515/H.R. 1260 Patent Reform Act of 2009 S.369 Preserve Access to Affordable Generics Act
H.R.1427/S.726 Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548 Pathway for Biosimilars Act S. 1695 Biologics Price Competition and Innovation Act of 2007 Health Care Reform H.R.1346/S.540 Medical Device Safety Act of 2009 H.R.759 Food and Drug Administration Globalization Act of 2009 S.882 Drug and Device Accountability Act of 2009 S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009 S. 1679 Affordable Health Choices Act H.R 3200 America's Affordable Health Choices Act of 2009 S. 1796 the Americas Healthy Future Act
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2009 · fourth_quarter · 4A
Health Care Reform S 1679: Affordable Health Choices Act S 1796: America's Healthy Future Act HR 3200: America's Affordable Health Choices Act H.R. 3962 Affordable Health Care for America Act H.R. 1548 Pathway for Biosimilars Act H.R.1346/S.540 Medical Device Safety Act of 2009 H.R. 3590 Patient Protection and Affordable Care Act S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009
S.510 FDA Food Safety Modernization Act H.R. 2749 Food Safety Enhancement Act of 2009 S.2766 Medical Foods Equity Act of 2009
S. 515/H.R. 1260 Patent Reform Act of 2009 S.369 Preserve Access to Affordable Generics Act
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2009 · fourth_quarter · Q4
S.510 FDA Food Safety Modernization Act H.R. 2749 Food Safety Enhancement Act of 2009 S.2766 Medical Foods Equity Act of 2009
Health Care Reform S 1679: Affordable Health Choices Act S 1796: America's Healthy Future Act HR 3200: America's Affordable Health Choices Act H.R. 3962 Affordable Health Care for America Act H.R. 1548 Pathway for Biosimilars Act H.R.1346/S.540 Medical Device Safety Act of 2009 H.R. 3590 Patient Protection and Affordable Care Act S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009
S. 515/H.R. 1260 Patent Reform Act of 2009 S.369 Preserve Access to Affordable Generics Act
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2009 · third_quarter · Q3
S. 515/H.R. 1260 Patent Reform Act of 2009 S.369 Preserve Access to Affordable Generics Act
H.R.1427/S.726 Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548 Pathway for Biosimilars Act S. 1695 Biologics Price Competition and Innovation Act of 2007 Health Care Reform H.R.1346/S.540 Medical Device Safety Act of 2009 H.R.759 Food and Drug Administration Globalization Act of 2009 S.882 Drug and Device Accountability Act of 2009 S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009 S. 1679 Affordable Health Choices Act H.R 3200 America's Affordable Health Choices Act of 2009 S. 1796 the Americas Healthy Future Act
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2009 · second_quarter · Q2
S. 515/H.R. 1260 Patent Reform Act of 2009 S.369 Preserve Access to Affordable Generics Act
H.R. 1- American Recovery and Reinvestment Act of 2009, including S.AMDT.112, S.AMDT.200 Proposals to extend the R&D tax credit Opportunities for Economic Stimulus Proposals regarding international revenue taxation
S.510 FDA Food Safety Modernization Act H.R.2749 Food Safety Enhancement Act of 2009
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2009 · first_quarter · Q1
Implementation of Medicare Improvements for Patients and Providers Act of 2008, sections 152-154 Implementation of DMEPOS Competitive Acquistion Program H.R. 684/S. 330 Medicare Prescription Drug Savings and Choice Act of 2009
H.R. 1- American Recovery and Reinvestment Act of 2009, including S.AMDT.112, S.AMDT.200 Proposals to extend the R&D tax credit Opportunities for Economic Stimulus
S. 515/H.R. 1260 Patent Reform Act of 2009
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2008 · fourth_quarter · Q4
H.R.1321/S.2404 Medicare Advanced Laboratory Diagnostics Act of 2007 H.R.6331/S.3101 - Medicare Improvements for Patients and Providers Act of 2008, implementation of sections 153, 154 Medicaid Implementation and Rebates
Intellectual Property Protection World Health Organization Initiatives
H.R.6381/S.3398 - Medical Device Safety Act of 2008 H.R.5839 - Safeguarding America's Pharmaceuticals Act of 2008 S.3385 - FDA Food Safety Modernization Act Health Care Reform S.2221 Transparency in Medical Device Pricing Act of 2007 S. 1695 Biologics Price Competition and Innovation Act of 2007 S. 623/H.R. 1038 Access to Life-Saving Medicine Act H.R.5629 Pathway for Biosimlars Act H.R.1956 Patient Protection and Innovative Biologic Medicines Act of 2007 S 2029 Physician Payments Sunshine Act of 2007 Topics relates to the safety of medical products H.R. 3610, the Food and Drug Import Safety Act S.2731/H.R. 5501 - Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis and Malaria Reuthorization Act of 2008
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2008 · third_quarter · Q3
Intellectual Property Protection World Health Organization Initiatives
H.R. 6331/S.3101 - Medicare Improvements for Patients and Providers Act of 2008, Section 153, 154 S.3118 - Preserving Access to Medicare Act of 2008, Section 152 H.R. 6252/S. 3144 Medicare DMEPOS Competitive Acquisition Reform Act of 2008 Protection of private sector delivery H.R. 1321 - Medicare Advanced Laboratory Diagnostics Act of 2007 Proposal to repeal CMS's Least Costly Alternative reimbursement policy for selected medicines H.R. 638/S. 3398 - Medicaid Device Safety Act of 2008 H.R.3162 - Children's Health and Medicare Protection Act of 2007 H.R.4854 - False Claims Act Correction Act of 2007 HR 3326 - Early Treatment for HIV Act of 2007
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2008 · second_quarter · Q2
H.R.3043 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008, amendment 3327 and Title II relating to chronic kidney disease awareness, funding for state AIDS drugs assistance programs, under the Ryan White Care Act. H.R. 3161, The Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2008 - Funding for the Food and Drug Administration
H.R. 6331/S.3101 - Medicare Improvements for Patients and Providers Act of 2008, Section 154 S.3118 - Preserving Access to Medicare Act of 2008, Section 152 H.R. 6252/S. 3144 Medicare DMEPOS Competitive Acquisition Reform Act of 2008 S. 1951/H.R. 3700: Fair Medicaid Drug Payment Act of 2007 H.R. 1321 - Medicare Advanced Laboratory Diagnostics Act of 2007 Proposal to repeal CMS's Least Costly Alternative reimbursement policy for selected medicines
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2008 · first_quarter · Q1
H.R.1908/S.1145 - Patent Reform Act of 2007
S. 2221 - Transparency in Medical Device Pricing Act of 2007 H.R. 1424, Paul Wellstone Mental Health and Addiction Equity Act of 2007 Implementation of Section 641 of public law 108-173, Medicare Prescription Drug Improvement and Modernization Act of 2003 HR 1321/S. 2404, Medicare Advanced Laboratory Diagnostics Act of 2007 Implementation of Section 302 of Public Law 108-173, Medicare Prescription Drug Improvement and Modernization Act of 2003
H.R.3043 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008, amendment 3327 and Title II relating to chronic kidney disease awareness, funding for state AIDS drugs assistance programs, under the Ryan White Care Act.
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2007 · year_end · YY
H.R.2419, Farm , Nutrition, and Bioenergy Act of 2007, Sections 11316 and 11317 H.R.1280, S. 714: Pet Safety and Protection Act of 2007
International Intellectual Property Protection World Health Organization initiatives
H.R. 1712: Research and Development Tax Credit Act of 2007 S. 41: Research Competitiveness Act of 2007
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2007 · mid_year · MM
Implementation of Public Law 108-265, Child Nutrition Improvement And Integrity Act
S. 736, Laboratory Test Improvement Act S. 1695, Biologics Price Competition and Innovation Act of 2007 H.R. 1038, S. 623, Access to Life-Saving Medicine Act H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007 S. 1505, Affordable Biologics for Consumers Act H.R. 2900, S.1082, Food and Drug Administration Revitalization Act S. 976, Genomics and Personalized Medicine Act of 2007
H.R. 1908, S.1145, Patent Reform Act H.R. 1432, Preserve Access to Affordable Generics Act
ABBOTT LABORATORIES via ABBOTT LABORATORIES
2006 · year_end · YY
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA), White House Office
Proposals regarding infant nutrition marketing. Issues related to international price controls on drugs and devices.
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
Policies to enhance patient access to medicines in Medicare Medicare payment proposals
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R.5973, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013
Implementation of Public Law 111-296 Healthy, Hunger-Free Kids Act of 2011 S.3240, Agriculture Reform, Food and Jobs Act of 2012 Initiatives regarding infant nutrition
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC)
Filing targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Securities & Exchange Commission (SEC), U.S. Trade Representative (USTR)
Implementation of Section 1502, Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010
Implementation of Public Law 110-275, Medicare DMEPOS Competitive Acquistion Program Proposals to expand competitive bidding for DMEPOS H.R. 675, Strenghten Medicare Anti-Fraud Measures Act of 2011 H.R. 3497, The MODDERN Cures Act of 2011 H.R. 3207, Modernizing Laboratory Test Standards for Patients Act of 2011 Proposals to give the Centers for Medicare and Medicaid authority to use the least costly alternative reimbursement policy Policies to enhance patient access to medicines in Medicare Reimbursement protocols for HIV diagnostics Medciare payment proposals
Filing targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Securities & Exchange Commission (SEC), White House Office
Implementation of Public Law 110-275 Medicare DMEPOS Competitive Acquistion Program Proposals to expand competitive bidding for DMEPOS S.17, Medical Device Access and Innovation Protection Act H.R. 675, Strengthening Medicare Anti-Fraud Measures Act of 2011 Proposals to give Center for Medicare and Medicaid Services authority to use the least costly alternative reimbursement policy Policies to enhance patient access to medicines in Medicare Reimbursement protocols for HIV diagnostics Medicare payment proposals
Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, The Reconciliation Act of 2010 S.319, The Pharmaceutical Market Access and Drug Safety Act of 2011 Reauthorization of The Prescription Drug User Fee Act of 2010 Reauthorization of The Medical Device User Fee Act of 2010 Policies for FDA product approval reform FDA proposals to enhance imported product safety
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE, State, Dept of (DOS)
Trade issues regarding the Trans-Pacific Partnership H.R.2112, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2012, amendment 36.
Implementation of Public Law 111-203, Dodd-Frank Wall Street Reform and Consumer Proctection Act of 2010, Section 1502
S.1002, SAFE DOSES Act
S.23, Patent Reform Act of 2011 H.R.243, Patent Lawsuit Reform Act of 2011 H.R. 1249, Leahy-Smith America Invents Act
Proposals to reform domestic and international tax structures
S.17, Medical Device Access and Innovation Protection Act H.R.675, Strengthening Medicare Anti-Fraud Measures Act of 2011 H.R.2190, Medicare Drug Savings Act of 2011 S.1206, Medicare Drug Savings Act of 2011
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Securities & Exchange Commission (SEC), White House Office
S.23, Patent Reform Act of 2011/ H.R. 243, Patent Lawsuit Reform Act of 2011
Trade issues regarding the Trans-Pacific Partnership International intellectual property protection
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Securities & Exchange Commission (SEC), State, Dept of (DOS), White House Office
Biodefense and pandemic preparedness appropriations
S.369 Preserve Access to Affordable Generics Act S. 3804 Combating Online Infringement and Counterfeits Act
PL-110-275 Implementation of Medicare DMEPOS Competitive Acquisition Program H.R. 3790 To amend title XVIII of the Social Security Act to repeal the Medicare competitive acquisition program for durable medical equipment and prosthetics, orthotics, and supplies (DMEPOS) in a budget neutral manner H.R.1321, S. 2404 Medicare Advanced Laboratory Diagnostics Act of 2007
S. 3307 Healthy, Hunger-Free Kids Act of 2010 H.R. 5504 Improving Nutrition for America's Children Act Special Supplemental Nutrition Program for Women, Infants and Children (WIC) Reauthorization Initiatives regarding infant nutrition
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
FY 2011 Budget Biodefense and pandemic preparedness appropriations Funding for state AIDS drug assistance programs under the Ryan White Care Act Appropriations for Food & Drug Administration (FDA) and Centers for Disease Control (CDC)
Proposals to extend the R&D tax credit Proposals regarding international revenue taxation H.R. 4173 Wall Street Reform and Consumer Protection Act of 2009 S. 3217 Restoring American Financial Stability Act of 2010 H.R. 4213 American Jobs and Closing Tax Loopholes Act of 2010
International Intellectual Property Protection
S. 515/H.R. 1260 Patent Reform Act of 2009 S.369 Preserve Access to Affordable Generics Act
H.R. 6331/S. 3101 Medicare Improvements for Patients and Providers Act of 2008, implementation of sections 153, 154
Filing targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Office of Management & Budget (OMB), SENATE, Treasury, Dept of
Proposals to extend the R&D tax credit Proposals regarding international revenue taxation H.R. 4173Wall Street Reform and Consumer Protection Act of 2009
S. 515/H.R. 1260 Patent Reform Act of 2009 S.369 Preserve Access to Affordable Generics Act
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, Natl Security Council (NSC), SENATE, U.S. Trade Representative (USTR)
H.R. 4678: Foreign Manufacturers Legal Accountability Act of 2010
H.R.4173/S.3217 Dodd-Frank Wall Street Reform and Consumer Protection Act S.3816 Creating American Jobs and Ending Offshoring Act H.R.5297 Small Business Jobs and Credit Act of 2010 Proposals Regarding International Revenue Taxation Proposals to Extend the R&D tax credit
S. 515/H.R. 1260 Patent Reform Act of 2009 S. 369 Preserve Access to Affordable Generics Act S. 3804 Combating Online Infringement and Counterfeits Act
S. 510 FDA Food Safety Modernization Act H.R.2749 Food Safety Enhancement Act of 2009
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE
Health Care Reform Implementation H.R. 3590 Patient Protection and Affordable Care Act H.R. 4872 Health Care and Education Reconciliation Act of 2010 Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, the Reconciliation Act of 2010 H.R. 1548 Pathway for Biosimilars Act S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009 S. 422 Heart Disease Education, Analysis Research, and Treatment for Women Act H.R. 4213 American Jobs and Closing Tax Loopholes Act of 2010 Proposals to address reimbursement of diagnostics Reauthorization of The Prescription Drug User Fee Act (PDUFA) Reauthorization of The Medical Device User Fee Act (MDUFA) Biodefense and pandemic preparedness H.R. 1345/S.540 Medical Device Safety Act of 2009 Policies for FDA product approval process Briefings on eye care
Proposals to extend the R&D tax credit Proposals regarding international revenue taxation H.R. 4173 Wall Street Reform and Consumer Protection Act of 2009 S. 3217 Restoring American Financial Stability Act of 2010 H.R. 4213 American Jobs and Closing Tax Loopholes Act of 2010
FY 2011 Budget Biodefense and pandemic preparedness appropriations Funding for state AIDS drug assistance programs under the Ryan White Care Act Appropriations for Food & Drug Administration (FDA) and Centers for Disease Control (CDC)
H.R. 6331/S. 3101 Medicare Improvements for Patients and Providers Act of 2008, implementation of sections 153, 154
Filing targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Office of Management & Budget (OMB), SENATE, Treasury, Dept of
FY 2011 Budget Biodefense and pandemic preparedness
S.510 FDA Food Safety Modernization Act H.R. 2749 Food Safety Enhancement Act of 2009 S.2766 Medical Foods Equity Act of 2009
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, Natl Security Council (NSC), SENATE, U.S. Trade Representative (USTR)
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE
S.510 FDA Food Safety Modernization Act H.R.2749 Food Safety Enhancement Act of 2009
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Implementation of Medicare Improvements for Patients and Providers Act of 2008, sections 152-154 Implementation of DMEPOS Competitive Acquistion Program H.R. 684/S. 330 Medicare Prescription Drug Savings and Choice Act of 2009
H.R.1427/S.726 Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548 Pathway for Biosimilars Act S. 1695 Biologics Price Competition and Innovation Act of 2007 Health Care Reform H.R. 1616 Early Treatment for HIV Act of 2009 H.R.1346/S.540 Medical Device Safety Act of 2009 Topics related to the safety of medical products Creating a federal program to strengthen awareness, education and treatment of chronic kidney disease H.R.759 Food and Drug Administration Globalization Act of 2009 S.882 Drug and Device Accountability Act of 2009 S.1213/H.R.2502 Patient-Centered Outcomes Research Act of 2009 S. 525, Pharmaceutical Market Access and Drug Safety Act of 2009
FY10 Federal Budget Funding for state AIDS drugs assistance programs under the Ryan White Care Act H.R. 1- American Recovery and Reinvestment Act of 2009, Part VI--Health Coverage Improvement
Filing targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
FY10 Federal Budget Funding for state AIDS drugs assistance programs under the Ryan White Care Act H.R. 1- American Recovery and Reinvestment Act of 2009, Part VI--Health Coverage Improvement
H.R.1427/S.726 Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548 Pathway for Biosimilars Act S. 1695 Biologics Price Competition and Innovation Act of 2007 Health Care Reform H.R. 1616 Early Treatment for HIV Act of 2009 H.R.1346/S.540 Medical Device Safety Act of 2009 Topics related to the safety of medical products H.R.759 Food and Drug Administration Globalization Act of 2009 Proposals impacting clinical research
Filing targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
H.R. 1908/S. 1145 - Patent Reform Act of 2007 S. 3600 Patent Reform Act of 2008
Filing targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
H.R.1908/S.1145 - Patent Reform Act of 2007 S. 3600 - Patent Reform Act of 2008
H.R. 6381- Medical Device Safety Act of 2008 H.R.5839 - Safeguarding America's Pharmaceuticals Act of 2008 S.3385 - FDA Food Safety Modernization Act Health Care Reform S.2731/H.R. 5501 Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008 H.R. 3580, the Food and Drug Administration Amendments Act of 2007 - issues related to implementation of the Prescription Drug User Fee Act. S.1695, Biologics Price Competition and Innovation Act of 2007 S.623/H.R. 1038 Access to Life-Saving Medicine Act H.R.5629 Pathway for Biosimilars Act H.R.1956 Patient Protection and Innovative Biologic Medicines Act of 2007
H.R.3043 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008, amendment 3327 and Title II relating to chronic kidney disease awareness, funding for state AIDS drugs assistance programs, under the Ryan White Care Act. S.Con.Res 70 - 2009 Federal Appropriations - funding for the Food and Drug Administration
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR)
H.R.1908/S.1145 - Patent Reform Act
H.R. 6381- Medical Device Safety Act of 2008 H.R.5839 - Safeguarding America's Pharmaceuticals Act of 2008 Issues related to potential FDA globalization legislation S.2731/H.R. 5501 Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008 H.R. 3580, the Food and Drug Administration Amendments Act of 2007 - issues related to implementation of the Prescription Drug User Fee Act. H.R. 4986, the National Defense Authorization Act - Section 703 - TriCare Retail Pharmacy S.1695, Biologics Price Competition and Innovation Act of 2007 S.623/H.R. 1038 Access to Life-Saving Medicine Act H.R.5629 Pathway for Biosimilars Act H.R.1956 Patient Protection and Innovative Biologic Medicines Act of 2007 S.334/H.R.3163, Healthy Americans Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
H.R. 3162, Childrens Health and Medicare Protection Act, Section 637 S. 2029 Physician Payments Sunshine Act of 2007 Implementation of H.R.3580, Food and Drug Administration Amendments Act of 2007 S.2731/H.R. 5501 Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008 S.1695, Biologics Price Competition and Innovation Act of 2007 S.623/H.R. 1038 Access to Life-Saving Medicine Act H.R.5629 Pathway for Biosimilars Act H.R.1956 Patient Protection and Innovative Biologic Medicines Act of 2007
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
H.R. 3580, the Food and Drug Administration Amendments Act of 2007 H.R. 1956, Patient Protection and Innovative Biologic Medicine Act of 2007 S. 1695: Biologics Price Competition and Innovation Act of 2007
H.R. 1321, S 2404: Medicare Advanced Laboratory Diagnostics Act of 2007 Implementation of Section 641 of Public Law 108-173, Medicare Prescription Drug, Improvement and Modernization Act of 2003
H.R.1908/S.1145 - Patent Reform Act of 2007, entire bill
H.R.3043/S.1710 FY 2008 - Departments of Labor, Health and Human Services, Education and Related Agencies Appropriations Act of 2008, Title II relating to chronic kidney disease awareness, funding for state AIDS Drug Assistance Programs under the Ryan White Care Act. H.R. 4986, the National Defense Authorization Act - Section 703 - TriCare Retail Pharmacy
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
International pharmaceutical market access Free trade agreements World Health Organization initiatives regarding pediatric nutrition International intellectual property protection
Implementation of Section 302 of Public Law 108-173, Medicare Prescription Drug, Improvement, and Modernization Act of 2003-relating to competitive bidding program for durable medical equipment. Implementation of Title 1 of Public Law 108-173, Medicare Prescription Drug, Improvement and Modernization Act of 2003-relating to Medicare prescrition drug benefit program Implementation of Title V of Public Law 109-171, Deficit Reduction Act H.R. 1321, Medicare Advanced Laboratory Diagnostics Act of 2007 H.R. 1193, S.691, Kidney Care Quality and Education Act of 2007 H.R. 4, S.3, Medicare Prescription Drug Price Negotiation Act of 2007 H.R. 3326, Early Treatment for HIV Act of 2007 Medicare reimbursement for glucose monitoring equipment Implementation of Section 641 of Public Law 108-173, Medicare Prescription Drug, Improvement, and Modernization Act of 2003-relating to demonstration project for self-injectable drugs.
H.R. 3043, S. 1710, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations for FY2008-relating to chronic kidney disease awareness, funding for state AIDS Drug Assistance programs under the Ryan White Care Act. H.R. 1585, S.1548, National Defense Authorization Act of FY2008-TriCare
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Natl Security Council (NSC), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office